ESMO Targeted Anticancer Therapies Congress 2026
16 Mars 2026 · 3 joursParis, FranceOncologieAnglais
À propos de ce congrès
The journey of innovation in cancer treatment begins with early drug development. ESMO TAT serves as a dynamic, multi-stakeholder forum, uniting researchers, industry leaders, investors, and regulators under one roof to accelerate the delivery of life-changing anticancer therapies to patients.
Join us in the pursuit to advance cancer treatment: we look forward to seeing you at this transformative event, to share new data, foster collaboration, and tackle challenges that will drive early clinical development forward.
Innovate. Collaborate. Advance.


